Uncloaking cell-impermeant gold nanorods via tumor microenvironmental cathepsin B facilitates cancer cell penetration and potent radiosensitization.
Cathepsin B
Cleavable peptide
Colorectal cancer
Gold nanorod
Radiation therapy
Journal
Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
19
05
2022
revised:
18
10
2022
accepted:
27
10
2022
pubmed:
12
11
2022
medline:
30
11
2022
entrez:
11
11
2022
Statut:
ppublish
Résumé
Major impediments to conveyance of intravenously administered drugs to tumors are biofouling, opsonization, and rapid clearance from the circulation by macrophages and reticuloendothelial phagocytes. Cloaking nanoparticles with stealth epilayers partly overcomes these hurdles but it also foils interactions with tumor cells. Here, we describe the synthesis, characterization, and validation of smart gold nanorods (GNRs) that spontaneously transform from inert passengers in the blood stream to active cell-penetrating nanoparticles within tumors to potently sensitize tumors to radiation therapy. Intrinsically cationic and cell-penetrating GNRs were shielded from phagocytosis with a cloaking polyethylene glycol epilayer containing an intervening cleavable peptide. In the absence of an external trigger, this epilayer is clipped off by the tumor microenvironmental protease, cathepsin B, in colorectal cancers to uncloak and expose the free-circulating native unPEGylated GNR that is readily internalized by cancer cells and turn into immovable small clusters of GNRs. Selective uncloaking of GNRs in the tumor reduced off-target toxicity confirmed by hematologic, biochemical, and histopathological analysis of blood, serum, and normal organs, respectively. Subsequent irradiation led to significant tumor growth delay and improved survival of mice. By addressing multiple barriers to efficient transport and cellular internalization of nanoparticles, our results demonstrate that clinically meaningful radiosensitization can be achieved with rationally designed GNRs.
Identifiants
pubmed: 36368139
pii: S0142-9612(22)00527-0
doi: 10.1016/j.biomaterials.2022.121887
pmc: PMC10032210
mid: NIHMS1848683
pii:
doi:
Substances chimiques
Gold
7440-57-5
Cathepsin B
EC 3.4.22.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
121887Subventions
Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA155446
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA257241
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE028105
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):189-205
pubmed: 26700713
Nanomedicine. 2015 Jul;11(5):1277-83
pubmed: 25652893
Biochim Biophys Acta. 2000 Mar 7;1477(1-2):215-30
pubmed: 10708859
Front Aging Neurosci. 2020 Aug 21;12:248
pubmed: 32973486
Transl Cancer Res. 2013 Aug 23;2(4):256-268
pubmed: 25279336
Horiz Cancer Res. 2015 2nd Quarter;56:23-40
pubmed: 26623174
Phys Med Biol. 2010 Feb 21;55(4):931-45
pubmed: 20090183
Nanomedicine. 2009 Jun;5(2):136-42
pubmed: 19480049
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
J Biomed Nanotechnol. 2014 Jul;10(7):1205-16
pubmed: 24804541
Nanotechnology. 2011 Jul 15;22(28):285101
pubmed: 21654036
J Proteome Res. 2011 Dec 2;10(12):5363-73
pubmed: 21967108
Nanotechnology. 2009 Sep 16;20(37):375101
pubmed: 19706948
Langmuir. 2020 Apr 14;36(14):3758-3769
pubmed: 32216357
Radiat Res. 2010 Jun;173(6):719-28
pubmed: 20518651
Appl Phys Lett. 2011 May 9;98(19):193702
pubmed: 21915155
Am J Physiol Gastrointest Liver Physiol. 2002 Sep;283(3):G794-800
pubmed: 12181196
J Control Release. 2000 Mar 1;65(1-2):271-84
pubmed: 10699287
Int J Nanomedicine. 2011;6:259-69
pubmed: 21423588
J Am Chem Soc. 2010 Feb 10;132(5):1517-9
pubmed: 20085324
Biochim Biophys Acta Proteins Proteom. 2021 Apr;1869(4):140604
pubmed: 33453413
Phys Med Biol. 2020 Oct 22;65(21):21RM02
pubmed: 32380492
Phys Med Biol. 2004 Sep 21;49(18):N309-15
pubmed: 15509078
Phys Med Biol. 2014 May 7;59(9):2249-63
pubmed: 24733041
Ann Transl Med. 2016 Dec;4(24):523
pubmed: 28151534
Biochemistry. 1995 Apr 11;34(14):4791-7
pubmed: 7718586
Mol Cancer. 2010 Aug 04;9:207
pubmed: 20684763
Med Phys. 2010 Jul;37(7):3809-16
pubmed: 20831089
Sci Rep. 2017 Dec 22;7(1):18044
pubmed: 29273727
Mol Carcinog. 2016 May;55(5):671-87
pubmed: 25808857
Phys Med Biol. 2010 Jun 7;55(11):3045-59
pubmed: 20463371